Regenerative Medical Technology RMTG Cash Flow Statement (2017-2026)

OTC RMTG
$0.04 +0.00 (+0.00%)
At close: Oct 19, 2026 · 4:00 PM EDT
Reported Financials

Regenerative Medical Technology Quarterly Cash Flow Statement

Periods 35 quarters
Latest Jun 2026

Regenerative Medical Technology reported cash from operations of $0.33M and free cash flow of $0.29M for the quarter ended Jun 2026, up 155.5% year over year. This cash flow statement covers 35 quarters of results from Dec 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-9.92M-1.57M-1.68M-1.49M-1.34M-1.06M-1.67M-2.03M-5.86M-0.26M-1.96M-2.08M-2.08M-0.64M-0.76M-1.44M-4.35M-1.39M-0.88M-2.91M
Depreciation and DepletionDep. & Depletion
0.03M0.03M0.07M0.07M0.05M0.06M0.06M-0.05M0.03M0.03M0.05M0.07M0.07M0.07M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.28M0.39M0.45M0.44M0.44M0.44M0.77M0.77M0.76M0.76M1.02M1.03M0.07M0.00M0.52M0.79M0.73M0.35M
Depreciation & Amortization (CF)Dep. & Amort.
0.01M0.03M0.03M0.04M0.04M0.05M0.06M0.06M0.10M0.10M0.08M0.08M0.09M-0.03M0.05M0.05M0.08M0.10M0.10M0.09M
Share-based CompensationStock Comp.
0.01M
Cash from Discontinued OperationsCash from Discont. Ops
76.00408.00-234.000.07M
Gains from Investment SecuritiesGains Investment
0.01M0.00M876.000.00M0.00M998.00964.00909.000.00M-708.000.00M885.000.00M-0.14M-865.000.92M1.08M-1.24M
Other non-cash itemsOther Non-Cash
0.49M0.02M1.60M1.60M-3.20M-1.51M1.85M1.86M-5.23M
Change in Working Capital
Change in ReceivablesChange Receivables
0.00M0.04M-0.04M0.06M-0.04M0.05M-0.05M-0.02M-0.01M0.02M-0.02M0.01M-0.01M-0.01M0.02M0.08M-0.07M-0.01M0.08M
Change in InventoryChange Inventory
0.00M0.01M0.08M0.05M0.00M0.14M0.18M
Change in Accured ExpensesChange Accured Exp.
0.59M0.50M0.83M0.49M0.78M0.41M0.91M0.75M0.87M0.88M1.01M1.03M1.02M1.04M0.91M0.66M3.19M1.39M1.47M1.75M
Change in Other Operating AssetsOther Assets Change
0.02M0.10M-0.10M0.01M0.03M-0.01M0.00M0.01M0.14M-0.03M-0.08M0.01M0.11M0.21M
Other Working Capital ChangesOther WC Changes
-0.02M-0.10M0.10M-0.01M-0.03M0.01M0.00M-0.01M-0.14M0.03M0.08M-0.01M-0.11M-0.21M
Cash from OperationsCash from Ops.
-0.43M-8.75M-0.52M-0.40M-0.15M-0.12M0.01M-0.41M0.01M-0.03M0.11M0.09M0.27M0.38M0.06M-0.60M-0.20M0.04M0.10M0.33M
Investing Activities
Capital ExpendituresCapex
0.00M0.07M0.01M0.00M0.09M0.28M0.06M0.05M0.05M0.05M0.22M0.27M0.32M0.04M
Change in Property, Plant and EquipmentChange in PP&E
0.00M-0.07M-0.01M0.00M-0.09M-0.28M-0.06M-0.05M-0.05M-0.05M-0.22M-0.27M-0.32M-0.04M
Acquisitions
-0.74M-0.17M
Net of Acquisitions & DivestmentsNet Acquisitions
0.74M0.17M
Other Investing ActivitiesOther investing
0.50M-12.65M
Cash from Investing ActivitiesCash from Investing
0.92M-180.000.00M-0.07M-0.01M0.00M-0.09M-0.28M-0.06M-0.05M-0.05M-0.05M-0.22M-0.27M-0.32M-0.04M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
1.00M0.32M-0.03M
Long-Term Debt RepaymentsLT Debt Repayment
0.00M0.00M0.01M0.00M0.01M0.01M
Non-Current Debt
1.00M0.00M-0.01M0.00M-0.01M-0.01M0.32M-0.03M
Net Debt Issuances and RepaymentsNet Debt Issuance
1.00M0.00M-0.01M0.00M-0.01M-0.01M0.32M-0.03M
Cash from Financing ActivitiesCash from Financing
-0.25M1.00M0.00M-0.01M0.00M-0.01M-0.01M-0.30M0.32M-0.03M
Additional items
Change in Cash
0.24M-7.75M-0.52M-0.54M-0.15M-0.12M-0.01M-0.41M-0.08M-0.61M0.05M0.04M0.22M0.33M0.06M0.39M-0.43M-0.23M0.10M0.26M
Ending Cash Balance
2.98M2.46M1.92M1.65M1.64M0.53M0.58M0.62M0.84M1.17M1.22M1.61M1.19M0.96M1.06M1.32M
Free Cash FlowFCF
-0.43M-8.75M-0.52M-0.40M-0.15M-0.19M0.00M-0.41M-0.08M-0.31M0.05M0.04M0.22M0.33M0.06M-0.60M-0.43M-0.23M-0.21M0.29M
Net Cash FlowNCF
0.24M-7.75M-0.52M-0.41M-0.15M-0.19M-0.01M-0.41M-0.08M-0.61M0.05M0.04M0.22M0.33M0.06M-0.60M-0.43M-0.23M0.10M0.26M
Interest Paid
118.0089.0058.0018.00

Regenerative Medical Technology Cash Flow Statement API

Pull Regenerative Medical Technology's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RMTG&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY